Abstract: . . .  2000;36:646-661. 15. American Diabetes Association. The treatment of hypertension in adult patients with diabetes (Technical Review). Diabetes Care . 2002; 25:134-147. 16. Moser M (letter). Is it time for a new approach to the initial treatment of hypertension . Arch Intern Med . 2001;161:1140- 1144. 17. Bakris GL, et al. Preserving renal function in adults with hyper- tension and diabetes: a consensus approach. AJKD . 2000:36:646-661. 18. Lewis EJ, Humsicker LG, Clarke WR, et al, for the Collaborative Study Group. Renoprotective effect of the angiotensin receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med . 2001;345:851-860. 19. Brenner BM, Cooper ME, DeZeeuw D, et al, for the RENAAL Study Investigators. Effects of losartan on renal and cardiovas- cular outcomes in patients with type 2 diabetes and nephropa- thy. N Engl J Med. 2001;345:861-869. 20. Bakris GL. A practical approach to achieving recommended blood pressure goals in diabetic patients. Arch Intern Med . 2001;161:2661-2667. 21. Tuomilehto J, Rastenyte D, Birkenhager WH, et al, for the Systolic Hypertension in Europe Trial Investigators. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension . N Engl J Med . 1999;340:677-684. 22. Neaton JD, Grimm RH, Prineas RJ, et al. Treatment of Mild Hypertension Study: Final Results. JAMA . 1993;2770:713-724. 23. Sowers JR, et al. for the National Heart Lung Blood Institute, NIH National High Blood Pressure Education Program (NHBPEP). World wide web at www.nhlbi.nih.gov/health/prof/heart/hbp/hpb_diab.htm accessed 10/11/01 . ACKNOWLEDGEMENTS University of Wisconsin Medical Foundation, University of Wisconsin Hospitals and Clinics, Meriter Hospital, Unity Health Insurance, Physicians Plus Insurance Corporation, Group Health Cooperative, and Community Physicians Network have cooperated in the revision of these guidelines. This task force was a multidisciplinary work group of physicians, nurse practitioners, pharmacists and a dietitian. Patrick McBride, MD and James Stein, MD, both faculty physicians at the University of Wisconsin Medical School, led the revision efforts. Additional contributors were: Bryan Becker, MD; Richard Day, MD; Lawrence Fleming, MD, MBA; Derek Hubbard, MD; Paul Kellerman, MD; Melissa Meredith, MD; Gail Underbakke, RD,MS; Marvin Wiener, MD. Please direct questions, comments and suggestions regarding these guidelines to Pam Kittleson, RPh, UWMF provider education phar- macist, at pamela.kittleson@uwmf.wisc.edu . Reviewed and updated August 2003 Scheduled for reconsideration third quarter 2005 Jointly sponsored by the University of Wisconsin Medical . . .
--3000,1,1500,3092,31882